Nanomedicine as a multimodal therapeutic paradigm against cancer: on the way forward in advancing precision therapy
Author:
Affiliation:
1. Institute for NanoBioTechnology, Department of Chemical and Biomolecular Engineering, Johns Hopkins University, Baltimore, MD, 21218, USA
2. Radiobiology, Department of Radiation Oncology & Homi Bhabha National Institute, Mumbai, 400012, India
Abstract
Publisher
Royal Society of Chemistry (RSC)
Link
http://pubs.rsc.org/en/content/articlepdf/2024/NR/D3NR06131K
Reference234 articles.
1. National Cancer Institute. (n.d.). Retrieved November 30, 2023, from https://www.cancer.gov/about-cancer
2. The global burden of cancer: priorities for prevention
3. The unique characteristics of tumor vasculature and preclinical evidence for its selective disruption by Tumor-Vascular Disrupting Agents
4. The role of hypoxia in the tumor microenvironment and development of cancer stem cell: a novel approach to developing treatment
5. Fifteen-Year Outcomes after Monitoring, Surgery, or Radiotherapy for Prostate Cancer
Cited by 2 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Two heads are better than one: Unravelling the potential Impact of Artificial Intelligence in nanotechnology;Nano TransMed;2024-12
2. Recent Treatment Strategies and Molecular Pathways in Resistance Mechanisms of Antiangiogenic Therapies in Glioblastoma;Cancers;2024-08-27
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3